agilon health Inc. has entered into an Amended and Restated Employment Agreement with Chief Financial Officer and Executive Vice President Jeffrey Schwaneke, effective January 1, 2026. Under the new agreement, Schwaneke will receive a one-time equity award of 600,000 restricted stock units vesting over three years. If his employment is terminated by the company without cause within 18 months of January 1, 2026, he will receive 12 months of base salary and target annual bonus as severance, payable over 12 months, and continued vesting of certain equity awards. The agreement also provides for annual equity awards for fiscal years 2026 and 2027, with the 2026 award valued at $3,750,000, subject to his continued employment at the time of grant.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. agilon health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-001168), on January 07, 2026, and is solely responsible for the information contained therein.